Foreign Drug Giants Undercut by Up to 95% in China Bidding

(Bloomberg) -- Global drugmakers from Merck & Co. to Novartis AG lost another slice of their lucrative China business, as domestic competitors undercut them with bids more than 95% lower to supply ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.